Evidence map›Paper›PMID 42098771›Full record

ArticleCell communication and signaling : CCS2026

Functional relationships linking C99/APP-βCTF dimerization, proteostasis disruption, and organelle dysfunction.

Céline Badot, Anaïs Bini, Eric Duplan, Frédéric Checler, Inger Lauritzen

Abstract read
In one paragraph

Article in Cell communication and signaling : CCS, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Céline BadotUniversité Côte d'Azur, CNRS UMR7275, INSERM U1323, Institute of molecular and cellular pharmacology, Laboratory of Excellence (LABEX) DistALZ, 660 route des Lucioles, Sophia-Antipolis, Valbonne, 06560, France.
Anaïs BiniUniversité Côte d'Azur, CNRS UMR7275, INSERM U1323, Institute of molecular and cellular pharmacology, Laboratory of Excellence (LABEX) DistALZ, 660 route des Lucioles, Sophia-Antipolis, Valbonne, 06560, France.
Eric DuplanUniversité Côte d'Azur, CNRS UMR7275, INSERM U1323, Institute of molecular and cellular pharmacology, Laboratory of Excellence (LABEX) DistALZ, 660 route des Lucioles, Sophia-Antipolis, Valbonne, 06560, France.
Frédéric CheclerUniversité Côte d'Azur, CNRS UMR7275, INSERM U1323, Institute of molecular and cellular pharmacology, Laboratory of Excellence (LABEX) DistALZ, 660 route des Lucioles, Sophia-Antipolis, Valbonne, 06560, France. Checler@ipmc.cnrs.fr.
Inger LauritzenUniversité Côte d'Azur, CNRS UMR7275, INSERM U1323, Institute of molecular and cellular pharmacology, Laboratory of Excellence (LABEX) DistALZ, 660 route des Lucioles, Sophia-Antipolis, Valbonne, 06560, France. Lauritzen@ipmc.cnrs.fr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe amyloid β (Aβ) precursor C99 (or APP-βCTF) accumulates in Alzheimer's disease and has been proposed to display Aβ-independent toxicity, notably by affecting the endosomal-lysosomal-autophagic (ELA) network. Our previous findings suggested that some ELA-associated C99 could correspond to dimeric and oligomeric species, but the intracellular sites of C99 dimerization, as well as the toxicity linked to it, remains unknown.

methodsWe here developed a bimolecular fluorescence complementation (BiFC) probe to visualize de novo C99 dimerization and dimer trafficking, as well as to identify possible cellular responses specifically linked to C99 dimerization. Moreover, to confirm dimer localizations and toxicities, the localization and cellular effects of the dimerization mutant C99

resultsBiFC-C99 dimers were first detected within the TGN, in which monomers initially accumulate. The proteasomal inhibitor MG-132 led to increased dimer formation, indicating that the proteasomal activity status is a key determinant of C99 dimerization. Conversely, TGN-associated C99 dimerization had a negative impact on both the ubiquitin-proteasome system (UPS) and the TGN, as highlighted by the appearance of p62/SQSTM1-positive aggresomes and fragmented Golgi, then suggesting a two-way relationship between UPS function and C99 dimerization. Dimerization also led to lysosome repositioning and to the accumulation of LC3B-positive autophagy vesicles, agreeing with the well-known interplay between autophagy and proteasome in protein turnover. P62/SQSTM1 and LC3B accumulation could similarly be observed in cells expressing C99

conclusionsTaken together, our findings indicate that the cellular status of UPS, autophagy and γ-secretase activities are all determinant for C99 expression levels, and are thus crucial for both the level of C99 dimerization and for the fate of the dimers. Moreover, our data show that C99 dimerization itself negatively affects these activities thereby indicating a two-way relationship between C99 dimerization, proteostasis disruption and organelle dysfunction.

Indexed as

Amyloid beta-Protein PrecursorProtein MultimerizationProteostasisAutophagyHeLa CellsHumansLysosomesProteasome Endopeptidase ComplexAmyloid beta-Protein PrecursorProteasome Endopeptidase ComplexAggresomesAutophagyBiFCC99 dimerizationC99 dimerization mutantEndosome-lysosome-autophagy compartmentsGolgi fragmentationSmall extracellular vesiclesUbiquitin-proteasome

Identifiers

PMID42098771
PMCPMC13317286

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.